Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Desvenlafaxine SR

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 29 USDMF, 15 EU WC, 13 KDMF, 15 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

140 FDF Dossiers, 39 FDA Orange Book, 14 Europe, 20 Canada, 40 Australia, 12 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 5 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Kirsch Pharma, 1 Panvo Organics, 1 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 1 Gloria Interchem, 5 Ideal Cures, 12 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 22 Lubricants & Glidants, 20 Thickeners and Stabilizers, 16 Topical, 12 Film Formers & Plasticizers, 11 Co-Processed Excipients, 9 Solubilizers, 9 Direct Compression, 8 Granulation, 7 API Stability Enhancers, 7 Disintegrants & Superdisintegrants, 5 Empty Capsules, 5 Taste Masking, 5 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Parenteral, 4 Vegetarian Capsules, 2 Coloring Agents, 2 Rheology Modifiers

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 18 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 5 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

12 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
31/03/2026	Aurobindo Pharma Limited	India	Aurobindo Pharma Limited	84386-186	Desvenlafaxine Succinate (Process-II)	2026-03-25	2027-12-31	BULK INGREDIENT	POWDER (50kg/50kg)
31/03/2026	Cadila Pharmaceuticals	India	Cadila Pharmaceuticals Limited	65691-0067	O-Desmethyl Venlafaxine Succinate	2009-01-22	2027-12-31	BULK INGREDIENT	POWDER (25kg/25kg)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Desvenlafaxine SR

Desvenlafaxine SR

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers

29 USDMF

15 EU WC

13 KDMF

15 NDC API

33 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

140 FDF Dossiers

39 FDA Orange Book

14 Europe

20 Canada

40 Australia

12 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem

2 SPI Pharma

5 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Kirsch Pharma

1 Panvo Organics

1 Cerata Pharmaceuticals LLP

2 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

3 Actylis

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

1 CD Formulation

1 Clariant

10 Corel Pharma Chem

2 DFE Pharma

1 Esteem Industries

2 Finar

7 Gangwal Chemicals

1 Gloria Interchem

5 Ideal Cures

12 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

8 Microlex e.U

1 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

1 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

9 Roquette

7 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

9 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

2 Ulanqab Kema New Material

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives